Biosignatures in ALS and FTD
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This trial collects biological samples from people with ALS or frontotemporal dementia (FTD) to find new markers that could lead to better understanding and treatment. You may be able to participate if you have been diagnosed with either condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ALS (using standard medical criteria)
- Or you have been diagnosed with frontotemporal dementia (FTD, using standard medical criteria)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
This study is a research collaborative that collects information from people with ALS or their families. It aims to better understand the disease and find markers that could help develop treatments.
This study looks for biological markers in the blood or other samples to track how ALS progresses over time. The goal is to catch changes earlier, which could help in future treatments.
This study builds a blood and spinal fluid (lumbar puncture) sample library from people with ALS, ALS-FTD, or similar neurodegenerative diseases. Your samples help researchers study these conditions, even if you are not receiving a new treatment.
This study looks at complex brain and body changes in people with ALS and frontotemporal dementia (FTD), or related disorders. If you have one of these diagnoses—or a known gene mutation that can cause ALS/FTD—you may be able to help researchers learn how the conditions progress.
Hear when a new FTD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.